[Skip to content]

Print this page
.

Local network oncology regimens

LMS Trial - Gemcitabine + Docetaxel followed by Doxorubicin

LMS Trial - Gemcitabine + Docetaxel followed by Doxorubicin
Summary: LMS - A phase III randomised trial of Gemcitabine plus Docetaxel followed by Doxorubicin versus Observation for uterine-limited, high-grade uterine Leiomyosarcoma. *** See trial protocol for further details ***
File Size: 234KB
File Type: application/pdf
Created: 12 April 2016
Last Modified: 15 April 2016